Felidale 1.25 mg coated tablets for cats
Felidale 1.25 mg coated tablets for cats
Authorised
- Thiamazole
Product identification
Medicine name:
Felidale 1.25 mg coated tablets for cats
Felidale 1,25 mg überzogene Tabletten für Katzen
Active substance:
- Thiamazole
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Thiamazole1.25/milligram(s)1.00Tablet
Pharmaceutical form:
-
Coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03BB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- (ID2) 100 Coated tablet: unspecified outer container with 4 Blister (PolyVinyl Chloride; PolyChloroTriFluoroEthylene) each with 25 Coated tablet, closed with Folie (Aluminium)
- (ID1) 100 Coated tablet: unspecified outer container with 1 Jar (PolyPropylene) with 100 Coated tablet, closed with Verschluss (Low Density PolyEthylene)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera Research Ltd.
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402454.00.00
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0307/001
Concerned member states:
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
